Security key
753018100
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)
CUSIP: 753018100
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Class A Common Stock, $0.0001 par value per share
- Total 13F shares
- 42,744,667
- Total 13F value
- $31,411,019
- Share change
- -2,092,107
- Put/Call ratio
- 2.8%
- SEC-reported price per share
- $0.73
- Number of holders
- 73
- Value change
- -$1,642,213
- Number of buys
- 30
- Number of sells
- 20
- Shares outstanding
- 116,468,828
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
73
Top holders
10
RANI full security history
Ownership snapshot
Full 13F holder table
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
InCube Labs, L.L.C.
Disclosed value leader
AWM Investment Company, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 22%
13D/G row: InCube Labs, L.L.C.
Showing 1-6 of 15 holder rows.
Quick read
InCube Labs, L.L.C. leads the comparable SEC ownership view at 22%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens InCube Labs, L.L.C.'s linked filing trail.
Comparable ownership
Top 5
InCube Labs, L.L.C.
22%
Invus Global Management, LLC
10%
AWM Investment Company, Inc.
9.9%
VANGUARD GROUP INC
5.2%
ARMISTICE CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| InCube Labs, L.L.C. |
13D/G
3/4/5
MIR A IMRAN · 10%+ Owner
|
22%
|
$13,541,357
27,093,552 shares
|
$0 | 23 Oct 2025 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
10%
|
$4,910,990
9,825,911 shares
|
$0 | 16 Oct 2025 |
| AWM Investment Company, Inc. |
13D/G
13F
Company
|
9.9%
|
$14,520,561
9,745,343 shares
|
$0 | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
5.2%
from 13D/G
|
$6,931,961
5,186,651 shares
mixed-class rows
|
— | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$2,865,831
2,515,652 shares
|
-$2,046,803 | 30 Sep 2025 |
| South Cone Investments Limited Partnership |
13D/G
3/4/5
10%+ Owner
|
4.9%
|
$1,189,121
2,379,194 shares
|
$0 | 20 Oct 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
73
Shares
42,744,667
Rows available
73
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
73
Q1 2026 holders
73
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|